STAT+: Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms 

Sen. Bob Menendez isn’t up for reelection until 2024, but pharma execs are flooding his campaign with cash — a sign of the central role he’ll play on drug pricing…

Click to view original post